TIG Portfolio

Yellowstone Biosciences

Yellowstone tasked TIG with the challenge of not only creating a new brand but also developing a complete visual and digital experience that would set them apart from their competitors. This included the creation of a brand identity, a carefully curated brand palette, visually appealing marketing materials, and a functional landing page website to showcase their offerings and communicate with potential clients and partners.

about

Yellowstone Therapeutics, a start-up in the biopharmaceutical sector, aims to unlock a new class of therapeutically targetable frequently expressed antigens with potential to significantly transform patient lives. Yellowstone has a novel approach to targeting a range of cancers. Spun out of the University of Oxford, Yellowstone is built around the pioneering research of Professor Paresh Vyas, a world-renowned scientific academic, key opinion leader and practising clinician with a specialist focus on acute myeloid leukaemia (AML). The Company is headquartered in Oxford, UK, with backing from a leading FTSE 250 healthcare company, Syncona.

DELIVERABLES:

brief

Yellowstone Therapeutics approached TIG with a goal of creating a strong and cohesive brand identity that would encapsulate their vision, mission, and core values. As a new company in the Therapeutics industry, they needed a brand that could reflect their innovative approach to Therapeutics and establish them as a credible and trustworthy brand in the field.

Our expertise in helping start-ups define their identity, coupled with our ability to translate scientific and technical concepts into approachable, compelling visual designs, made us the ideal partner for this project. Yellowstone needed a branding partner that could understand the complexities of their industry and help them establish a strong market presence from the outset—and TIG was well-equipped to meet these needs.